The blood-brain barrier is notoriously difficult to model in the lab—until now. AIM’s proven technology and world-class contract research lab can get you better BBB data faster with our human-on-a-chip in vitro models.

AIM Biotech co-founder Roger Kamm, PhD gives a sneak peek into his opening keynote at next week’s free workshop about M-CELS. Read on to see his personal insights as a leader in this growing field.

A free workshop this June about M-CELS will feature AIM Biotech co-founder Roger Kamm, PhD. As a keynote speaker, he’ll discuss his perspectives as a pioneering researcher at MIT.